Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study.
Hans-Peter HartungTobias DerfussBruce Anthony Campbell CreeMaria Pia SormaniKrzysztof SelmajJonathan StuttersFerran PradosDavid MacManusHans-Martin SchnebleEstelle LambertHervé PorchetRobert GlanzmanDavid WarneFrancois CurtinGabrielle KornmannBénédicte BuffetDavid KremerPatrick KüryDavid LeppertThomas RückleFrederik BarkhofPublished in: Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
CHANGE-MS: ClinicalTrials.gov: NCT02782858, EudraCT: 2015-004059-29; ANGEL-MS: ClinicalTrials.gov: NCT03239860, EudraCT: 2016-004935-18.